Cases of Anaplastic Large-Cell Lymphoma of Breast Up in U.S. Women
Authors suggest increase may be associated with increasing prevalence of textured implants during the same period.
Non-Hodgkin Lymphoma
Pola-R-CHP May Be Cost Effective, Depending on PFS Outcomes in Previously Untreated DLBCL
Researchers sought to determine whether the combination pola-R-CHP would be cost-effective for treating patients with previously untreated DLBCL.
Zanubrutinib May Improve Response Rate Compared With Ibrutinib in Waldenström Macroglobulinemia
Researchers sough to determine whether zanubrutinib would improve responses compared with ibrutinib in patients with Waldenström macroglobulinemia.
Vaccine-Induced Responses to Omicron, Delta Impaired in Non-Hodgkin Lymphoma Patients
Of the NHL patients with neutralizing antibodies against the WA1/2020 SARS-CoV-2 strain, 70% had antibodies against the delta variant, and 33% had antibodies against the omicron variant.
Bone Marrow Infiltration a Risk Factor for Infusion-Related Reactions in B-Cell NHL
A retrospective study of patient data sought to determine if bone marrow infiltration is linked to adverse effect severity in patients with CD20-positive B-NHL.
Geriatric Assessment Better Than Chronologic Age for Measuring Health-Related Quality of Life in NHL
A prospective study sought to determine the value of geriatric assessment in patients with non-Hodgkin lymphoma, compared with assessment based on chronological age.
Brentuximab Vedotin Provides ‘Robust Clinical Benefit’ in Cutaneous T-Cell Lymphoma
Time to next treatment was significantly longer with brentuximab vedotin.
Effect of Bundle Nursing on Thrombosis Risk in Patients With Non-Hodgkin Lymphoma
A single-institution study determined the effect of a novel nursing practice on incidence of PICC-UEDVT, outcomes, and satisfaction with care in patients with NHL.
Baseline SUVmax May Have Prognostic Value in Patients With Follicular Lymphoma
Researchers sought to determine whether baseline SUVmax would have prognostic value in patients with follicular lymphoma.
Brentuximab Vedotin May Improve Outcomes in Anaplastic Large Cell Lymphoma
Researchers sought to determine whether adding brentuximab vedotin to chemotherapy would be safe and effective in pediatric patients with ALCL.
- Loading...
Loading...
Next post in Lymphoma
Loading... 
Loading...